These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 32603839

  • 1. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z, Zhang Y, Zhu C, Guo T, Xia Q, Hou X, Liu W, Feng N.
    Int J Pharm; 2020 Aug 30; 586():119576. PubMed ID: 32603839
    [Abstract] [Full Text] [Related]

  • 2. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z, Zhang Y, Zhang K, Wu Z, Feng N.
    Artif Cells Nanomed Biotechnol; 2018 Aug 30; 46(sup1):578-587. PubMed ID: 29374971
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy.
    Li B, Tan T, Chu W, Zhang Y, Ye Y, Wang S, Qin Y, Tang J, Cao X.
    Drug Deliv; 2022 Dec 30; 29(1):75-88. PubMed ID: 34964421
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB, Chen XJ, Fan XD, Zhu JJ, Wei YH, Zheng HS, Zheng HY, Wang BH, Piao JG, Li FZ.
    Acta Pharmacol Sin; 2021 May 30; 42(5):832-842. PubMed ID: 33824461
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
    Chen C, Hu H, Qiao M, Zhao X, Wang Y, Chen K, Guo X, Chen D.
    Int J Pharm; 2015 Mar 01; 480(1-2):116-27. PubMed ID: 25615984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy.
    He L, Qing F, Li M, Lan D.
    Int J Nanomedicine; 2020 Mar 01; 15():2337-2349. PubMed ID: 32308385
    [Abstract] [Full Text] [Related]

  • 13. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J, Fan K, Jin Y, Zhao L, Wang Q, Tang Y, Xu H, Liu Z, Wang S, Lin J, Lin D.
    Eur J Pharm Sci; 2019 Dec 01; 140():105070. PubMed ID: 31518679
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy.
    Khatri H, Chokshi N, Rawal S, Patel BM, Badanthadka M, Patel MM.
    Int J Pharm; 2020 Jun 15; 583():119386. PubMed ID: 32376440
    [Abstract] [Full Text] [Related]

  • 17. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.
    Int J Nanomedicine; 2015 Jun 15; 10():2101-14. PubMed ID: 25844039
    [Abstract] [Full Text] [Related]

  • 18. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S, Li L, Su XT, Wang K, Lu ZJ, Yuan CZ, Feng JB, Yan S, Kong BH, Song K.
    J Exp Clin Cancer Res; 2018 Feb 26; 37(1):29. PubMed ID: 29478415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
    Fahmy HM, Ahmed MM, Mohamed AS, Shams-Eldin E, Abd El-Daim TM, El-Feky AS, Mustafa AB, Abd Alrahman MW, Mohammed FF, Fathy MM.
    BMC Pharmacol Toxicol; 2022 Sep 26; 23(1):71. PubMed ID: 36163187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.